iMCD in Focus 2020

What?

A leading global company in iMCD management wanted to conduct an annual educational event for HCPs to help them to better understand the process for diagnosing and treating iMCD. The goal of the event was to bring the healthcare community together to share expertise.

Why?

iMCD is rare, with non-specific symptoms, making if difficult to diagnose. Diagnostic and treatment guidelines have been published, but use of these key resources is patchy and imperfect. HCP education is central to improving patient outcomes.

How?

Through yearly collaboration with an expert steering committee, Enzyme Communications supported the planning, development, and execution of this international multi-day event. A strong brand for the event was created to help drive attendance. Over multiple years (and adaptations due to the Covid pandemic), this event has provided quality education and a forum for expert collaboration.

Results?

The event has been attended by more than 250 healthcare professionals from more than 25 countries over three years.